Park Ha Biological Technology Co., Ltd. balance sheet

At the end of fiscal 2025, Park Ha Biological Technology Co., Ltd. had total assets of $6.0m, total liabilities of $2.0m and shareholders' equity of $4.0m. It held $3.8m in cash against $0 of debt: net cash of $3.8m.

Balance sheet

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Park Ha Biological Technology Co., Ltd.: balance sheet, annual
Fiscal year	2022Oct 2022	2023Oct 2023	2024Oct 2024	2025Oct 2025
Cash and equivalents	575	1,034	547	3,788
Receivables	—	362	331	256
Inventory	—	96	71	75
Total current assets	—	2,176	2,844	5,502
Total assets	—	2,265	3,083	5,953
Accounts payable	—	197	24	12
Deferred revenue (current)	—	251	326	195
Total current liabilities	—	1,243	1,524	1,882
Total debt	0	0	0	0
Total liabilities	—	1,252	1,577	1,958
Shareholders' equity	150	1,012	1,506	3,995
Net debt (negative = net cash)	−575	−1,034	−547	−3,788

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: BYAH vs SNES BYAH vs ZONE BYAH vs CITR BYAH vs REFR

More: Specialty Chemicals stocks compared, Materials sector, rankings of US companies

Figures from Park Ha Biological Technology Co., Ltd.'s SEC filings (10-K and 10-Q). How we read and check them: methodology and data sources. Not investment advice. Back to Park Ha Biological Technology Co., Ltd.